Furthermore, AMPs can modulate the immune cells within the tumor microenvironment, such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), which often suppress the immune response and promote tumor growth. The gene discussed is ADSL; the disease is neoplasm.